Eutropics to support development of Tolero's blood cancer therapy

01/15/2014 | GenomeWeb Daily News (free registration)

Eutropics and Tolero Pharmaceuticals have formed a strategic alliance, which involves the use of Eutropics' PraediCare Dx technology to help develop Tolero's alvocidib. The experimental compound is in late-stage trials and is being developed as a treatment for patients with acute myelogenous leukemia and chronic lymphocytic leukemia.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC